Digital destination for sophisticated men & women. Live your best life with expert tips and news on health, food, sex, relationships, fashion and lifestyle.
Our content is fact checked by our senior editorial staff to reflect accuracy and ensure our readers get sound information and advice to make the smartest, healthiest choices.
"NAION is relatively rare, occurring up to 10 out of 100,000 people in the general population," the researchers noted in the release."NAION is the second-leading cause of optic nerve blindness and it is the most common cause of sudden optic nerve blindness." Their analysis found that people who had diabetes and had been prescribed semaglutide were over four times more likely to be diagnosed with NAION. They also discovered that those who were overweight or had obesity and had been prescribed this medication were more than seven times more likely to be diagnosed with NAION.
"Our findings should be viewed as being significant but tentative, as future studies are needed to examine these questions in a much larger and more diverse population," Rizzo explained."This is information we did not have before and it should be included in discussions between patients and their doctors, especially if patients have other known optic nerve problems like glaucoma or if there is preexisting significant visual loss from other causes.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Maker of Ozempic, Wegovy to build massive facility in North CarolinaRooted in fact-based, transparent reporting, Newsy is an award-winning opinion-free network owned by the E.W. Scripps Company that is relentlessly focused on “the why” of every story and seeks to enable a more intimate and immersive understanding of the issues that matter.
Read more »
Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, OzempicThe new plant in Clayton, North Carolina, will be responsible for filling and packaging syringes and injection pens for Wegovy, Ozempic and other drugs.
Read more »
Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, OzempicThe new plant in Clayton, North Carolina, will be responsible for filling and packaging syringes and injection pens for Wegovy, Ozempic and other drugs.
Read more »
Ozempic and Wegovy may reduce inflammation by targeting the brainWeight-loss injections such as Wegovy reduce inflammation in the body by acting on brain cells, according to a study in mice
Read more »
Fake Wegovy and Ozempic warnings: What to knowWHO and Eli Lilly has warned consumers to be cautious of counterfeit versions of popular weight-loss and diabetes drugs like Wegovy, Ozempic being sold online.
Read more »
Bernie Sanders: Ozempic, Wegovy drugmaker is 'ripping off' U.S. over weight loss drug costBerkeley Lovelace Jr. is a health and medical reporter for NBC News. He covers the Food and Drug Administration, with a special focus on Covid vaccines, prescription drug pricing and health care. He previously covered the biotech and pharmaceutical industry with CNBC.
Read more »